Muscle Power in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.


Journal

International journal of sports medicine
ISSN: 1439-3964
Titre abrégé: Int J Sports Med
Pays: Germany
ID NLM: 8008349

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 23 6 2023
pubmed: 23 2 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

This study aimed to review the impact of training on muscle power in patients with chronic obstructive pulmonary disease (COPD). Randomized controlled trials evaluating the effects of exercise-based interventions on limbs muscle power and rate of force development in COPD patients were investigated. Five international databases were searched until October 2022. Meta-analyses were performed calculating the mean difference or standardized mean difference. Risk of bias in studies was assessed using Cochrane Risk of Bias tool 2.0. A total of nine studies were included in the analysis. There were concerns about risk of bias in seven out of nine studies. Comparison of exercising and non-exercising groups showed a significant effect of exercise in improving muscle power (P=0.0004) and rate of force development (P<0.001), in five and three trials, respectively. Four studies comparing different trainings showed no significant results on muscle power (P=0.45). Eight to 16 weeks of exercise-based intervention versus no intervention might be beneficial to enhance upper and lower limbs muscle power and rate of force development in people with COPD. In contrast, muscle power did not improve when different training modalities were compared. Future studies performing power training in COPD patients are encouraged.

Identifiants

pubmed: 36807279
doi: 10.1055/a-1982-9902
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

463-472

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Simone Pancera (S)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Nicola Francesco Lopomo (NF)

Department of Information Engineering, University of Brescia, Brescia, Italy.

Riccardo Buraschi (R)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Joel Pollet (J)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Paolo Pedersini (P)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Stefano Giuseppe Lazzarini (SG)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Luca Nicola Cesare Bianchi (LNC)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH